↓ Skip to main content

Omalizumab in patients with severe asthma and persistent sputum eosinophilia

Overview of attention for article published in Allergy, Asthma & Clinical Immunology, April 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news
1 news outlet
policy
1 policy source
twitter
2 X users

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
22 Mendeley
Title
Omalizumab in patients with severe asthma and persistent sputum eosinophilia
Published in
Allergy, Asthma & Clinical Immunology, April 2019
DOI 10.1186/s13223-019-0337-2
Pubmed ID
Authors

Manali Mukherjee, Melanie Kjarsgaard, Katherine Radford, Chynna Huang, Richard Leigh, Delbert R. Dorscheid, Catherine Lemiere, Louis-Philippe Boulet, Susan Waserman, James Martin, Parameswaran Nair

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 22 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 18%
Student > Master 4 18%
Student > Bachelor 3 14%
Unspecified 1 5%
Other 1 5%
Other 1 5%
Unknown 8 36%
Readers by discipline Count As %
Medicine and Dentistry 8 36%
Biochemistry, Genetics and Molecular Biology 2 9%
Unspecified 1 5%
Pharmacology, Toxicology and Pharmaceutical Science 1 5%
Economics, Econometrics and Finance 1 5%
Other 1 5%
Unknown 8 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2024.
All research outputs
#2,657,238
of 25,385,509 outputs
Outputs from Allergy, Asthma & Clinical Immunology
#149
of 925 outputs
Outputs of similar age
#57,850
of 364,727 outputs
Outputs of similar age from Allergy, Asthma & Clinical Immunology
#6
of 26 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 925 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.8. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,727 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.